PMC:7417114 / 29737-30206 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T170","span":{"begin":140,"end":148},"obj":"Body_part"},{"id":"T171","span":{"begin":190,"end":198},"obj":"Body_part"},{"id":"T172","span":{"begin":396,"end":404},"obj":"Body_part"}],"attributes":[{"id":"A170","pred":"fma_id","subj":"T170","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A171","pred":"fma_id","subj":"T171","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A172","pred":"fma_id","subj":"T172","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T354","span":{"begin":239,"end":248},"obj":"Disease"},{"id":"T355","span":{"begin":316,"end":324},"obj":"Disease"},{"id":"T356","span":{"begin":342,"end":350},"obj":"Disease"}],"attributes":[{"id":"A354","pred":"mondo_id","subj":"T354","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A355","pred":"mondo_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A356","pred":"mondo_id","subj":"T356","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T367","span":{"begin":279,"end":280},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T368","span":{"begin":297,"end":304},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T369","span":{"begin":386,"end":394},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T370","span":{"begin":435,"end":443},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T253","span":{"begin":140,"end":148},"obj":"Chemical"},{"id":"T254","span":{"begin":190,"end":198},"obj":"Chemical"},{"id":"T255","span":{"begin":458,"end":468},"obj":"Chemical"}],"attributes":[{"id":"A253","pred":"chebi_id","subj":"T253","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A254","pred":"chebi_id","subj":"T254","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A255","pred":"chebi_id","subj":"T255","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"994","span":{"begin":316,"end":324},"obj":"Species"},{"id":"995","span":{"begin":329,"end":337},"obj":"Species"},{"id":"996","span":{"begin":342,"end":352},"obj":"Species"},{"id":"997","span":{"begin":239,"end":248},"obj":"Disease"}],"attributes":[{"id":"A994","pred":"tao:has_database_id","subj":"994","obj":"Tax:694009"},{"id":"A995","pred":"tao:has_database_id","subj":"995","obj":"Tax:1335626"},{"id":"A996","pred":"tao:has_database_id","subj":"996","obj":"Tax:2697049"},{"id":"A997","pred":"tao:has_database_id","subj":"997","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T94","span":{"begin":211,"end":228},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T95","span":{"begin":211,"end":228},"obj":"http://purl.obolibrary.org/obo/GO_0019058"},{"id":"T96","span":{"begin":451,"end":468},"obj":"http://purl.obolibrary.org/obo/GO_0033673"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T234","span":{"begin":0,"end":12},"obj":"Sentence"},{"id":"T235","span":{"begin":13,"end":77},"obj":"Sentence"},{"id":"T236","span":{"begin":78,"end":92},"obj":"Sentence"},{"id":"T237","span":{"begin":93,"end":353},"obj":"Sentence"},{"id":"T238","span":{"begin":354,"end":367},"obj":"Sentence"},{"id":"T239","span":{"begin":368,"end":469},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T60","span":{"begin":342,"end":352},"obj":"SP_7"}],"text":"Left Column: Drug names and disease indication, and main therapeutic targets. Middle Column: Potency (based on KINOMEscan data) against key proteins associated with respiratory function and proteins involved in viral replication/life span/infection- believed to be necessary for a wide variety of viruses, including SARS-CoV and MERS-CoV and SARS-CoV-2. Right column: Anti-inflammatory activity, cytokine suppression, and antifibrotic activity of the kinase inhibitors."}